Hospira Receives FDA Approval For Meropenem For Injection, USP (I.V.)

Links shared publicly online about this topic.

1,071
total visits

Hospira Receives FDA Approval For Meropenem For Injection, USP (I.V.)

Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, announced it has received U.S. Food and Drug Administration (FDA) approval for meropenem for injection, USP (I.V

View full resource at medicalnewstoday.com

Tags: Drug, Pharma, FDA, Antibiotic, Merrem

Most Recently Shared on June 24, 2010 at 1:07 pm By:

MNT Drug Approvals

Hospira Receives FDA Approval For Meropenem For Injection, USP (I.V.) http://mnt.to/3Fhm #regulatory

2 years ago...

Retweet

Favorite

Also Shared By:

MNT Infect Diseases

FDA approves Hospira's meropenem for injection, USP (I.V.)

news-medical.net — “Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced it has received U.S. Food and Drug Administration (FDA) approval for meropenem for injection, USP (I.V.) 500 mg and 1 g vials. The medication, a carbapenem that belongs to the beta-lactam class of antibiotics, is a generic version of AstraZeneca's Merrem® I.V. Sales of the name-brand product in the United States were approximately $200 million in 2009.” View full resource at news-medical.net